Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of topical roflumilast cream 0.3% for plaque psoriasis in China
CTR20243985Phase 3Completed
- Sponsor
- Arcutis Biotherapeutics
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roflumilast in plaque psoriasis, sponsored by Arcutis Biotherapeutics. Started Oct 2024; status: completed.
02
Drugs
roflumilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20243985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243985.